Truist Reiterates Hold Rating on Medpace (MEDP) Amid 'Choppy Macro'
Tweet Send to a Friend
Truist Securities analyst Jailendra Singh reiterated a Hold rating and $300.00 price target on Medpace (NASDAQ: MEDP).The analyst commented: "Macro ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


